GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's other long-term assets for the quarter that ended in Sep. 2014 was $7,241 Mil.
GlaxoSmithKline PLC's quarterly other long-term assets increased from Mar. 2014 ($7,437 Mil) to Jun. 2014 ($7,766 Mil) but then declined from Jun. 2014 ($7,766 Mil) to Sep. 2014 ($7,241 Mil).
GlaxoSmithKline PLC's annual other long-term assets increased from Dec. 2011 ($7,157 Mil) to Dec. 2012 ($7,168 Mil) and increased from Dec. 2012 ($7,168 Mil) to Dec. 2013 ($7,412 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
GlaxoSmithKline PLC Annual Data
|Other Long-Term Assets||5,918||5,823||7,017||7,349||6,468||7,066||7,904||7,157||7,168||7,412|
GlaxoSmithKline PLC Quarterly Data
|Other Long-Term Assets||8,009||8,349||7,168||7,231||7,398||7,554||7,412||7,437||7,766||7,241|